Vaccines

Inactivated

Vaccine Type

Inactivated

Composition

Each dose contains not less than a pre-inactivation titer of 1 x 108.5 EID50 of Newcastle disease virus.

Indication

An inactivated strain developed for use in chickens and breeder hens to give broad protection against Newcastle disease. It also provides high levels of parental immunity in the progeny.

Vaccination Program

  • The birds should be ‘primed’ with a live virus Newcastle disease vaccine at least 4 weeks prior to administration of this inactivated vaccine.
  • The first dose of this vaccine should be administered at 16-20 weeks of age, along with the live vaccine.
  • A dose of 0.5 ml per bird is recommended.
  • If birds are held for a second year, breeders should revaccinate during molt.

Administration

This vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days of slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 500 and 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.

 

Vaccine Type

Inactivated

Composition

Each dose contains not less than a preinactivation titer of 1 x 106.2 TCID50 of Infectious Bursal disease virus.

Indication

An inactivated strain developed for use in breeder hens to give broad protection against Infectious Bursal disease (Gumboro disease). Additionally, it gives high levels of parental immunity to the progeny.

Vaccination Program

  • The birds should be ‘primed’ with a mild or intermediate strain of live virus IBD vaccine at least 4 weeks prior to administration of this inactivated vaccine.
  • The vaccine should be administered at 16-20 weeks of age.
  • A dose of 0.5 ml per bird is recommended.
  • If birds are held for a second year, breeders should revaccinate during molt.

Administration

This vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days of slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 500 and 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.

Vaccine Type

Inactivated

Composition

Each dose contains not less than a pre-inactivation titer of 1 x 106.9 EID50 of Avian Infectious Bronchitis virus.

Indication

An inactivated vaccine developed for breeder hens and commercial layers to provide broad protection, throughout the production lifecycle, against different strains of Avian Infectious Bronchitis. Additionally, it gives high levels of parental immunity to the progeny. Untreated early infection with IB can cause loss of egg production capability, reducing profitability of the flock.

Vaccination Program

  • The birds should be ‘primed’ with a mild or intermediate strain of live virus Infectious Bronchitis vaccine at least 4 weeks prior to administration of this inactivated vaccine.
  • The vaccine should be administered at 16-20 weeks of age.
  • A dose of 0.5 ml per bird is recommended.
  • If birds are held for a second year, breeders should revaccinate during molt.

Administration

This vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days of slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.

Vaccine Type

Inactivated

Composition

Each dose contains not less than a pre-inactivation titer of 1 x 109 EID50 of Newcastle Disease virus and 1 X 106.9 EID50 of Avian Infectious Bronchitis virus.

Indication

An inactivated vaccine developed for breeder hens and commercial layers to provide broad protection, throughout the production lifecycle, against Newcastle disease and Infectious Bronchitis. Additionally, it gives high levels of parental immunity to the progeny.

Vaccination Program

  • The birds should be ‘primed’ with a live virus Newcastle disease and Infectious Bronchitis vaccine at least 4 weeks prior to administration of this inactivated vaccine.
  • The vaccine should be administered at 16-20 weeks of age.
  • A dose of 0.5 ml per bird is recommended.
  • If the birds are held for a second year, breeders should revaccinate during molt.

Administration

This vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region, using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days of slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.

Vaccine Type

Inactivated

Composition

Each dose contains not less than a pre-inactivation titer of 1 x 109 EID50 Newcastle Disease virus and 1 x 106.2 TCID50 Infectious Bursal disease virus.

Indication

An inactivated vaccine developed for breeder hens to provide broad protection, throughout the production lifecycle, against Newcastle disease and Gumboro disease. Additionally, it gives high levels of parental immunity to the progeny.

Vaccination Program

  • The birds should be ‘primed’ with a live virus Newcastle disease and Infectious Bursal vaccine at least 4 weeks prior to administration of this inactivated vaccine.
  • A dose of 0.5 ml per bird is recommended.
  • The vaccine should be administered at 16-20 weeks of age.
  • If the birds are held for a second year, breeders should revaccinate during molt.

Administration

This vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region, using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days of slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 500 and 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.

Vaccine Type

Inactivated

Composition

Each dose contains not less than 2000 hemagglutinating units of inactivated adenovirus and pre-inactivation titer of 1 X 109 EID50 Newcastle Disease virus and 1 X 106.2 TCID50 Infectious Bursal disease virus.

Indication

An inactivated vaccine developed with high tittering strains for breeder hens to provide broad protection, throughout the production lifecycle, against Newcastle disease, Infectious Bursal disease (Gumboro disease), and Egg Drop Syndrome. Additionally, it gives high levels of parental immunity to the progeny.

Vaccination Program

  • The birds should be ‘primed’ with a live virus vaccines for Gumboro and Newcastle disease at least 4 weeks prior to use.
  • Vaccinate with this vaccine between 16 to 20 weeks of age.
  • A dose of 0.5 ml per bird is recommended.
  • If birds are held for a second year, breeders should revaccinate during molt.

Administration

The vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region, using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days before slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.

Vaccine Type

Inactivated

Composition

Each dose contains not less than a pre-inactivation titer of 1 x 109 EID50 Newcastle Disease virus, 1 x 106.2 TCID50 Infectious Bursal disease virus, and 1 x 105.8 TCID50 1733 and 1 x 106.3 TCID50 S1133 strains.

Indication

An inactivated vaccine developed for breeder hens and replacement pullets to provide broad protection against Newcastle disease and Type 1 Infectious Bursal Disease (Gumboro disease). Additionally, it also provides maternal antibodies for the early protection of the progeny against Reo virus related malabsorbtion syndrome and tenosynovitis.

Vaccination Program

  • The birds should be ‘primed’ with a live virus Newcastle vaccine between 10 to 14 days of age, and again at 12 weeks of age.
  • Prime with weakened live tenosynovitis vaccine at 7 days of age, and again at 12 weeks of age.
  • Additionally, prime with mild or intermediate strain of live IBD virus at 21 days and again at 12 weeks of age.
  • Vaccinate with this vaccine between 6 to 20 weeks of age.
  • A dose of 0.5 ml per bird is recommended.
  • If birds are held for a second year, breeders should revaccinate during molt.

Administration

The vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region, using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days before slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.

Vaccine Type

Inactivated

Composition

Each dose contains not less than a pre-inactivation titer of 1 x 109 EID50 Newcastle Disease virus, 1 x 106.2 TCID50 Infectious Bursal disease virus and 1 x 106.9 EID50 of Avian Infectious Bronchitis virus.

Indication

An inactivated vaccine developed for breeder hens and replacement pullets to provide broad protection, throughout the production lifecycle, against Newcastle disease, Infectious Bronchitis originating from the Massachusetts type strain, and Gumboro Disease. Additionally, it gives high levels of parental immunity to the progeny.

Vaccination Program

  • The birds should be ‘primed’ with a live virus Newcastle-Bronchitis vaccine between 10 to 14 days of age, and again at 12 weeks of age.
  • Additionally, prime with mild or intermediate strain of live IBD virus at 21 days and again at 12 weeks of age.
  • Vaccinate with this vaccine between 16 to 20 weeks of age.
  • A dose of 0.5 ml per bird is recommended.
  • If birds are held for a second year, breeders should revaccinate during molt.

Administration

The vaccine should be brought to room temperature before use. It must be injected subcutaneously in the lower neck region, using standard aseptic techniques. Ensure that all birds in the flock are properly vaccinated, but do not vaccinate within 42 days before slaughter.

Pack Size & Storage

The vaccine is available in 500 ml polypropylene bottles and 18 bottles are packed per case. Each bottle contains 1000 doses of the vaccine. Protect the vaccine from light and store between 2°C and 8°C; do not freeze it.